Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Adenovirus: early-phase trial registry
6 of 7 indexed Adenovirus trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 6 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Adenovirus: 7 US clinical trials tracked, 6 recruiting.
Adenovirus is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is Jessie L. Alexander, running 2 of these trials.
Enrollment posture brief
Registry condition adenovirus
OPEN 6 | RECR 86% | LATE 0 | EARLY 7 | RANK #2497 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Advanced Soft Tissue Sarcoma (86% recruiting · 7 trials)
Adenovirus lists 6 open slots (86% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Adenovirus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Adenovirus is recruiting above its size-band peers.
6 of 7 indexed trials (85.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Adenovirus research.
Jessie L. Alexander accounts for 2 of 7 trials (28.6%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Adenovirus trials plan to enrol fewer than 100 people.
Median target enrolment is 25 among the 7 trials that report a genuine target (sentinel values excluded). 7 of those (100%) plan for fewer than 100 participants.
-
Adenovirus research is mostly interventional.
7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation
St. Jude Children's Research Hospital
NCT05664126
R-MVST Cells for Treatment of Viral Infections
Columbia University
NCT05183490
Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
Jessie L. Alexander
NCT06909110
Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
Sumithira Vasu
NCT03665675
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
New York Medical College
NCT03266627
R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
Columbia University
NCT06926894
Viral Specific T-Lymphocytes to Treat Adenovirus or CMV
Jessie L. Alexander
NCT04364178
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Adenovirus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Adenovirus trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Adenovirus page
7 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Adenovirus trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Jessie L. Alexander sponsors the most Adenovirus trials on record, review their full trial history before evaluating a specific study. See Jessie L. Alexander's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Adenovirus condition card totals 7 registered trials; most-linked intervention Cytomegalovirus Specific T-Lymphocytes; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.